Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Clinical trial NCT05164016 · COMPLETED

Trial details

NCT number: NCT05164016
Sponsor: St. Jude Children's Research Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer Hematopoietic System--Cancer Transplant-Related Cancer Solid Tumor Malignancy Hematologic Malignancy Solid Organ Transplant Hematopoietic Cell Transplant Cellular Therapy

Start date: 2022-06-29
Primary completion: 2025-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.